The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Chemistry and Cancer Preventing Activities of Ginseng Saponins and Some Related Triterpenoid Compounds
Open accessAbstract
More than 25 dammarane-type tetracyclic triterpenoid saponins have been isolated from ginseng, the root and rhizome of Panax ginseng C.A. Meyer (Araliaceae). The genuine sapogenins of those saponins, 20(S)-protopanaxa-diol and -triol, were identified as 20(S) 12beta-hydroxy-and 20(S) 6alpha,12beta-dihydroxy-dammarenediol-II, respectively. There are two types of preparations from ginseng: white ginseng prepared by drying after peelling off and red ginseng prepared by steaming and drying. Some partly deglycosylated saponins such as ginsenoside Rh-1, Rh-2, and Rg-3 are obtained from red ginseng as artifacts produced during steaming. Several workers studied the metabolic transformation by human intestinal bacteria after oral administration of ginsenoside Rb-1 and Rb-2 and found that the stepwise deglyco-sylation yielded compound K and finally 20(S)-protopanaxadiol. Ginsenoside Rg-1 was converted into 20(S)-protopanaxatriol via ginsenoside Rh-1. Yun et al. in Korea conducted the epidemiological case-control studies of ginseng and suggested its cancer preventing activities. Kitagawa et al. demonstrated in vitro that ginsenosides, especially 20(R)-ginsenoside Rg-3, specifically inhibited cancer cell invasion and metastasis. Azuma et al. found that ginsenoside Rb-2 inhibited tumor angiogenesis, and Kikuchi et al. reported that ginsenoside Rh-2 inhibited the human ovarian cancer growth in nude mice. Recently, ginsenoside Rg-3 was produced as an anti-angiogenic anti-cancer drug in China. The aforementioned reports suggest that less glycosylated protopanaxadiol derivatives are effective in cancer prevention. Apart from Ginseng tetracyclic triterpenoid saponins, some oleanane-type pentacyclic triterpenoid compounds showed the anti-carcinogenic activity in the two-stage anti-cancer-promotion experiments in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Progress in the Chemistry of Organic Natural Products 109
(2019) · Progress in the Chemistry of Organic Natural Products · doi:10.1007/978-3-030-12858-6 · Cited by 2,052
Constitutive .BETA.-Glucosidases Hydrolyzing Ginsenoside Rb1 and Rb2 from Human Intestinal Bacteria.
BAE, E.-A., PARK, S.-Y., & KIM, D.-H. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.1481 · Cited by 238
Inhibition of Tumor Angiogenesis and Metastasis by a Saponin of Panax ginseng, Ginsenoside-Rb2.
SATO, K., MOCHIZUKI, M., SAIKI, I., YOO, Y., SAMUKAWA, K., & AZUMA, I. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.635 · Cited by 211
Nakata, H., Kikuchi, Y., Tode, T., Hirata, J., Kita, T., Ishii, K., Kudoh, K., Nagata, I., & Shinomiya, N. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03278.x · Cited by 182
Yun, T.-K., & Choi, S. (1995) · PubMed · Cited by 174
Nishino, H., Nishino, A., Takayasu, J., Hasegawa, T., Iwashima, A., Hirabayashi, K., IWATA, S., & Shibata, S. (1988) · PubMed · Cited by 174
Self-citationShibata, S., Tanaka, O., Ando, T., Sado, M., Tsushima, S., & Ohsawa, T. (1966) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.14.595 · Cited by 135
Self-citationInhibition of in vitro Tumor Cell Invasion by Ginsenoside Rg3
Shinkai, K., Akedo, H., Mukai, M., Imamura, F., Isoai, A., Kobayashi, M., & Kitagawa, I. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb00230.x · Cited by 126
Update from Asia: Asian Studies on Cancer Chemoprevention
Yun, T.-K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08734.x · Cited by 125
Studies on saponins and sapogenins of ginseng the structure of panaxatriol
Shibata, S., Tanaka, O., Soma, K., et al. (1965) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)99595-4 · Cited by 105
Self-citationKikuchi, Y., Sasa, H., Kita, T., Hirata, J., Tode, T., & Nagata, I. (1991) · Anti-Cancer Drugs · doi:10.1097/00001813-199102000-00009 · Cited by 101
Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides.
Odashima, S., Ohta, T., Kohno, H., Matsuda, T., Kitagawa, I., Abe, H., & Arichi, S. (1985) · PubMed · Cited by 91
Hasegawa, H., Ki-Seung, L. E. E., Nagaoka, T., Tezuka, Y., Uchiyama, M., Kadota, S., & Saiki, I. (2000) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.23.298 · Cited by 88
Nishino, H., Yoshioka, K., Iwashima, A., et al. (1986) · PubMed · Cited by 62
Induction of phenotypic reverse transformation by ginsenosides in cultured Morris hepatoma cells
Odashima, S., Nakayabu, Y., Honjo, N., Abe, H., & Arichi, S. (1979) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(79)90230-5 · Cited by 56
Kanaoka, M., Kato, H., SHIMADA, F., & Yano, S. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.314 · Cited by 21
Cited by
Biological activities and distribution of plant saponins
Sparg, S. G., Light, M. E., & van Staden, J. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.05.016 · Cited by 1,446
Pharmacological activities of natural triterpenoids and their therapeutic implications
Dzubak, P., Hajduch, M., Vydra, D., Hustova, A., Kvasnica, M., Biedermann, D., Markova, L., Urban, M., & Sarek, J. (2006) · Natural Product Reports · doi:10.1039/b515312n · Cited by 708
Saponins as cytotoxic agents: a review
Podolak, I., Galanty, A., & Sobolewska, D. (2010) · Phytochemistry Reviews · doi:10.1007/s11101-010-9183-z · Cited by 704
Christensen (2008) · doi:10.1016/s1043-4526(08)00401-4 · Cited by 504
DEGRADATION OF GINSENOSIDES IN HUMANS AFTER ORAL ADMINISTRATION
Tawab, M. A., Bahr, U., Karas, M., Wurglics, M., & Schubert-Zsilavecz, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1065 · Cited by 439
Metadata
- Authors
- Shibata, S.
- Venue
- Journal of Korean Medical Science
- Publisher
- Korean Academy of Medical Sciences
- Published
- 2001
- Volume
- 16
- Issue
- Suppl
- Pages
- S28
- ISSN
- 1011-8934 (ISSN-L)
- 1598-6357
- OpenAlex
- W2142921795
- Cited by
- 449
- References
- 16
- Type
- conference abstract
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.